SRA's number for the day: 2,325,000
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration's fee for manufacturers who want to use the agency's priority review voucher program for drugs for tropical diseases will rise to $2,325,000 in fiscal year 20141.